Clinical trial
Chest Pain Pilot Study
NCT00251901 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00251901 |
|---|---|
| Title | Chest Pain Pilot Study |
| Official title | A Randomized Double-Blind Placebo-Controlled Multi-Centre Pilot Study to Assess Symptom Response in Subjects With Pain or Discomfort in the Chest Receiving Oral Treatment With Esomeprazole 40 mg Bid for 4 Weeks. |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chest Pain, Gastroesophageal Reflux |
| Intervention type | Drug |
| Interventions | Esomeprazole |
| Enrollment | 600 |
| Start date | May 1, 2004 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Nov 11, 2005 |
| Last update posted | Jan 24, 2011 |
| Countries | Canada, Denmark, Germany, Netherlands, Norway, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: